Deletion of FoxO1, 3, and 4 in Osteoblast Progenitors Attenuates the Loss of Cancellous Bone Mass in a Mouse Model of Type 1 Diabetes
Open Access
- 4 August 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 32 (1) , 60-69
Abstract
Type 1 diabetes is associated with osteopenia and increased fragility fractures, attributed to reduced bone formation. However, the molecular mechanisms mediating these effects remain unknown. Insulin promotes osteoblast formation and inhibits the activity of the FoxO transcription factors. FoxOs, on the other hand, inhibit osteoprogenitor proliferation and bone formation. Here, we investigated whether FoxOs play a role in the low bone mass associated with type 1 diabetes, using mice lacking FoxO1, 3, and 4 in osteoprogenitor cells (FoxO1,3,4ΔOsx1‐Cre). Streptozotocin‐induced diabetes caused a reduction in bone mass and strength in FoxO‐intact mice. In contrast, cancellous bone was unaffected in diabetic FoxO1,3,4ΔOsx1‐Cre mice. The low bone mass in the FoxO‐intact diabetic mice was associated with decreased osteoblast number and bone formation, as well as decreased expression of the anti‐osteoclastogenic cytokine osteoprotegerin (OPG) and increased osteoclast number. FoxO deficiency did not alter the effects of diabetes on bone formation; however, it did prevent the decrease in OPG and the increase in osteoclast number. Addition of high glucose to osteoblastic cell cultures decreased OPG mRNA, indicating that hyperglycemia in and of itself contributes to diabetic bone loss. Taken together, these results suggest that FoxOs exacerbate the loss of cancellous bone mass associated with type 1 diabetes and that inactivation of FoxOs might ameliorate the adverse effects of insulin deficiency. © 2016 American Society for Bone and Mineral Research.Keywords
Funding Information
- National Institutes of Health (R01 AR56679, P01 AG13918, R01 DK055653)
This publication has 70 references indexed in Scilit:
- Wnt/β-Catenin Signaling and DiseaseCell, 2012
- Matrix-embedded cells control osteoclast formationNature Medicine, 2011
- Insulin Signaling in Osteoblasts Integrates Bone Remodeling and Energy MetabolismCell, 2010
- Insulin Receptor Signaling in Osteoblasts Regulates Postnatal Bone Acquisition and Body CompositionCell, 2010
- FoxO-Mediated Defense against Oxidative Stress in Osteoblasts Is Indispensable for Skeletal Homeostasis in MiceCell Metabolism, 2010
- FoxO3 Regulates Neural Stem Cell HomeostasisCell Stem Cell, 2009
- FoxOs Cooperatively Regulate Diverse Pathways Governing Neural Stem Cell HomeostasisCell Stem Cell, 2009
- Streptozotocin, Type I Diabetes Severity and BoneBiological Procedures Online, 2009
- Skeletal Involution by Age-associated Oxidative Stress and Its Acceleration by Loss of Sex SteroidsJournal of Biological Chemistry, 2007
- FoxOs Are Lineage-Restricted Redundant Tumor Suppressors and Regulate Endothelial Cell HomeostasisCell, 2007